The global atrial fibrillation devices market valued US$ 4,984.9 Mn in 2018 and expected to attain US$ 19,967.3 Mn by 2027.
Abbott Laboratories, Johnson & Johnson, Atricure Inc., Microport Scientific Corporation, Boston Scientific Corporation, St. Jude medical, Inc., Medtronic Plc, Koninklijke Philips N.V., and Siemens AG are some of the major industry participants operating in the global atrial fibrillation devices market.
The main objective of this report is to define, describe, and forecast the global atrial fibrillation devices market on the basis of types of applications, major sectors, deployment models, organization size, and regions. This report mainly introduces volume and value market share by segments and also their price change details. The analysis includes the market by value, by segments, by application, by manufacturers and by region. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2019 to 2027. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2019 to 2027, considering 2018 as the base year. All market data presented in revenues, shipments and installed base, along with average pricing data.
The report contains an analysis of the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges). It aims to strategically analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the market. The report also offers insightful and detailed information regarding the various key players operating in the global market, and their financials, apart from strategies, acquisitions & mergers, and market footprint.
The report forecasts the market size, in terms of value, for various segments with regard to four main regions—North America, Europe, APAC, and RoW. It strategically profiles key players and comprehensively analyzes their market rankings and core competencies, along with detailing the competitive landscape for the market leaders.
The report also tracks and analyzes competitive developments, including partnerships, collaborations, acquisitions, new product developments, and R&D activities in the market. The report analyze detailed profiles of 20+ innovative and leading vendors, with information on products and services, target markets, strategy, SWOT analysis, key relationships and capital funding.
The research methodology used to estimate and forecast the market begins with capturing data on key vendor’s revenues through secondary research. The vendor offerings are also taken into consideration to determine the market segmentation. The bottom-up procedure was employed to arrive at the overall market size of the global market from the revenue of the key players in the market. After arriving at the overall market size, the total market was split into several segments and sub-segments, which were then verified through primary research by conducting extensive interviews with key people, such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures were employed to complete the overall market engineering process and to arrive at the exact statistics for all segments and sub-segments.
Product Type Segment (2019–2027; US$ Mn)
Electrophysiology Ablation Catheters
Electrophysiology Diagnostic Catheters
Fixed Diagnostic Catheters
Steerable Diagnostic Catheters
Electrophysiology Mapping and Recording Systems
Left Atrial Appendage (LAA) & Closure Devices
Intracardiac Echocardiography (ICE) Systems & Others
End-use Segment (2019–2027; US$ Mn)
Ambulatory Surgery Centers (ASCs)
Others (electrophysiology labs, catheterization laboratories)
Geography Segment (2019–2027; US$ Mn)
Rest of Europe
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Key questions answered in this report
What are the current market trends and dynamics in the atrial fibrillation market and valuable opportunities for emerging players?
Which product contributes to the maximum market share?
Which product accounts for the fastest CAGR during the forecast period?
Which end-user holds a larger market share and why?
What is the impact of pharmaceutical drugs on the atrial fibrillation devices market?
Are low and middle-income economies investing in the atrial fibrillation devices market?
What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?